VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Intuit Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Intuit Inc.
INTU · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Intuit Inc.'s moat claims, evidence, and risks.
View INTU analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Intuit Inc. leads (76 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Intuit Inc. has 4 segments (58.8% in Global Business Solutions); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Intuit Inc. has 8 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
Intuit Inc.
Global Business Solutions
Small and mid-market business financial management, payroll, payments/capital, and marketing automation software (QuickBooks ecosystem + Mailchimp)
Global
Small businesses, mid-market businesses, and accounting/bookkeeping professionals
SaaS platform operator and payments/embedded-finance enabler
58.8%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Intuit Inc. strengths
Sanofi strengths
Segment mix
Intuit Inc. segments
Full profile >Global Business Solutions
Oligopoly
Consumer
Oligopoly
Credit Karma
Competitive
ProTax
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.